Van Dijk 2002.
Study characteristics | ||
Methods |
Study design: Double‐blind, randomized clinical trial Study grouping: Intermittent morphine versus continuous morphine |
|
Participants |
Baseline Characteristics Inclusion criteria: Children aged 0–3 years, admitted for major abdominal or thoracic surgery. In addition, included patients were neonates (greater than or equal to 35 weeks gestation and body weight greater than or equal to 1500 g) and infants aged up to 3 years. Exclusion criteria: Exclusion criteria were use of analgesic or sedative co‐medication (e.g. acetaminophen or midazolam) influencing the measured amount or potency of morphine, use of neuromuscular blockers, hepatic or renal dysfunction, seriously compromised neurological status, or altered muscle tone. Pretreatment: Anesthetic management was standardized. Perioperative fluids were standardized to maintain a glucose infusion rate between 4 and 6 mg/kg/min; body temperature was kept within normal ranges. After the first arterial blood sample (baseline), patients received a second dose of 5 mcg/kg of fentanyl before surgical incision. At the end of surgery, all patients were given an intravenous loading dose of 100 mg/kg morphine. |
|
Interventions |
Intervention Characteristics Continuous infusion versus bolus administration
|
|
Outcomes |
Pain assessed with validated methods during the administration of selected drugs
Pain was assessed with the behavioral part of the COMFORT scale. In addition, the nurses completed an observational VAS for a clinical rating of pain in each child. |
|
Identification |
Sponsorship source: Supported by the Dutch Organization for Scientific Research Country: The Netherlands Setting: Neonatal Intensive Care Unit Comments: None Authors names: Monique van Dijk, Nancy J. Bouwmeester, Hugo J. Duivenvoorden, Hans M. Koot, Dick Tibboel, Jan Passchier, Josien B. de Boer Institution: Department of Pediatric Surgery, Erasmus MC‐Sophia Email: vandijk@psys.azr.nl Address: Department of Pediatric Surgery, Erasmus MC‐Sophia, Rotterdam, The Netherlands |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | "Infants within these age categories were randomly assigned to CM or IM administration." "The hospital pharmacist prepared the study drugs; the randomization schedule was known to the pharmacist only and retained until the end of the trial." Not specified how the randomization schedule was generated |
Allocation concealment (selection bias) | Low risk | "The hospital pharmacist prepared the study drugs; the randomization schedule was known to the pharmacist only and retained until the end of the trial". |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | "The hospital pharmacist prepared the study drugs; the randomization schedule was known to the pharmacist only and retained until the end of the trial." Blinded |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | "Pharmacist prepared the study drugs; the randomization schedule was known to the pharmacist only and retained until the end of the trial. Pain was assessed prior to surgery." Blinded |
Incomplete outcome data (attrition bias) All outcomes | Low risk | "Excluded infants did not significantly differ with regard to background characteristics, except age. This is primarily due to the low number of excluded neonates." "204 infants were allocated to this trial. However, five were lost to follow‐up; one infant died within the first hours after surgery due to irreversible pulmonary hypertension, three patients had a failing arterial line, and one patient experienced clinical signs of ventilatory depression. In addition, 18 patients were excluded because they did not comply with the inclusion criteria:" |
Selective reporting (reporting bias) | Unclear risk | No registry reported so unable to compare to protocol |
Other bias | Low risk | None |